Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Incannex Healthcare Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 0 | 7 | +7 |
| Shares | 0 | 84.3K | +84.3K |
| Value | $0 | $804.0K | +$804.0K |
New holders (7)
Institutions that held Incannex Healthcare Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 37,815 | $378.0K | 0.00% |
| Morgan Stanley | 20,000 | $183.0K | 0.00% |
| Citadel Advisors LLC | 12,016 | $110.0K | 0.00% |
| Old Mission Capital LLC | 10,000 | $92.0K | 0.00% |
| UBS Group AG | 2,757 | $25.0K | 0.00% |
| Barclays PLC | 1,709 | $16.0K | 0.00% |
| Citigroup Inc | 6 | $0 | 0.00% |
Sold out (0)
Institutions that held Incannex Healthcare Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
None.